Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Shigella Sonnei Infection”

19 trials

Showing 19 of 19 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06838195
What this trial is testing

Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate Vaccine

Who this might be right for
DysenteryDysentery, Shigella
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 8,000
Early research (Phase 1)Study completedNCT02034500
What this trial is testing

Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults

Who this might be right for
Shigellosis
GSK Vaccines Institute For Global Health S.r.l. 52
Large-scale testing (Phase 3)Study completedNCT00368316
What this trial is testing

Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel

Who this might be right for
Shigellosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2,799
Early research (Phase 1)Study completedNCT04992520
What this trial is testing

Controlled Human Infection Model Challenge/Rechallenge

Who this might be right for
Shigellosis
PATH 46
Testing effectiveness (Phase 2)WithdrawnNCT03038243
What this trial is testing

Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in Adults

Who this might be right for
Shigella Sonnei Dysenteries
PATH
Testing effectiveness (Phase 2)Study completedNCT02676895
What this trial is testing

The Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults

Who this might be right for
Shigella Sonnei Infection
GlaxoSmithKline 74
Early research (Phase 1)Study completedNCT02816346
What this trial is testing

Dose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge Strain

Who this might be right for
Healthy
PATH 56
Large-scale testing (Phase 3)UnknownNCT05156528
What this trial is testing

Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years

Who this might be right for
DysenteryShigellosis
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 21,000
Early research (Phase 1)Study completedNCT01336699
What this trial is testing

Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3

Who this might be right for
Shigella Infection
National Institute of Allergy and Infectious Diseases (NIAID) 89
Not applicableStudy completedNCT02516683
What this trial is testing

The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study

Who this might be right for
Shigella Sonnei Infection
Yonsei University 229
Testing effectiveness (Phase 2)Study completedNCT04242264
What this trial is testing

Phase 2 Shigella Vaccine and Challenge

Who this might be right for
ImmunisationShigella Infection
National Institute of Allergy and Infectious Diseases (NIAID) 69
Testing effectiveness (Phase 2)Study completedNCT03527173
What this trial is testing

Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults

Who this might be right for
Dysentery, Bacillary
GlaxoSmithKline 71
Early research (Phase 1)Study completedNCT02017899
What this trial is testing

A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.

Who this might be right for
Shigellosis
GSK Vaccines Institute For Global Health S.r.l. 50
Testing effectiveness (Phase 2)Study completedNCT05073003
What this trial is testing

A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants

Who this might be right for
Diarrhoea
GlaxoSmithKline 551
Early research (Phase 1)Looking for participantsNCT05959616
What this trial is testing

Shigella Sonnei 53G Human Infection Study in Kenyan Adults

Who this might be right for
Shigellosis
University of Oxford 70
Testing effectiveness (Phase 2)Study completedNCT01080716
What this trial is testing

Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate

Who this might be right for
DysenteryShigellaDiarrhea
U.S. Army Medical Research and Development Command 30
Early research (Phase 1)Study completedNCT03089879
What this trial is testing

Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study

Who this might be right for
Dysentery, Bacillary
GlaxoSmithKline 35
Early research (Phase 1)WithdrawnNCT01399424
What this trial is testing

Shigella Sonnei OSPC-rDT Conjugate Vaccine

Who this might be right for
Shigellosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not applicableStudy completedNCT01813071
What this trial is testing

Safety Study of Live Attenuated Oral Shigella (WRSS1) Vaccine in Bangladeshi Adults and Children

Who this might be right for
Diarrhea
PATH 103

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation